Aurobindo Pharma planning to launch 50-60 new products in US in FY21

22 Jun 2020 Evaluate

Aurobindo Pharma is planning to launch 50 to 60 new products in US in FY21. The company has received final approval for six ANDAs (Abbreviated New Drug Application) and launched four products in the fourth quarter of last fiscal. For the full year, it has received approval for 22 ANDAs and launched 34 products across oral, injectable and OTC segments.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1212.30 61.75 (5.37%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×